Disease/Infection News

RSS

Prevalence of persistent Long COVID symptoms after SARS-CoV-2 infection

In a new study, researchers aimed to analyze the prevalence and severity of persistent symptoms in the first year of COVID-19 infection as compared to non-infected individuals.

13 Jan 2022

Analyzing milk produced after maternal COVID-19 diagnosis for the presence of SARS-CoV-2

A recent paper in the journal Frontiers in Immunology describes the demonstration of mucosal antibodies in breast milk that specifically target the virus.

13 Jan 2022

Researchers develop a website to identify SARS-CoV-2 regional clusters in real-time

Researchers have empowered public health officers to explore the spread of SARS-CoV-2 across the USA and even support public health groups globally to quickly understand and apply insights obtained from the most recent genomic data.

13 Jan 2022

Vaccination offers long-term protection from worst outcomes of COVID-19

Vaccination offers long-lasting protection from the worst outcomes of COVID-19, according to a new study by the University of North Carolina at Chapel Hill.

13 Jan 2022

Role of leptin in immune modulation and pathophysiology of COVID-19

A recent review paper in the journal Frontiers in Physiology discusses the role of leptins in infection with SARS-CoV-2 that triggered the ongoing COVID-19 pandemic.

13 Jan 2022

Study finds SARS-CoV-2 infection caused significant changes in the levels of stress associated small RNAs

In this study, researchers described the effect of significant changes of small RNAs in the post-transcriptional regulatory network.

13 Jan 2022

Exploring healthcare workers' opinions on mandatory COVID-19 vaccination in the UK

In a new study, researchers determined healthcare workers' views on mandatory severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in the United Kingdom.

13 Jan 2022

SARS-CoV-2-specific immune responses elicited by inactivated COVID-19 vaccines

In this study, researchers identified and recruited volunteers who received inactivated COVID-19 vaccines in real-world settings.

13 Jan 2022

Exploring factors favoring transmission of SARS-CoV-2 Delta sublineage AY.4.2 over the Delta variant

In the present study, researchers isolated an infectious AY.4.2 strain of COVID-19 from the nasopharyngeal swab of a symptomatic individual from the Paris region. Then, they introduced the AY.4.2 signature mutations - T95I, Y145H, and A222V - in an expression plasmid coding the Delta protein to study the function of the AY.4.2 S protein.

13 Jan 2022

Forecasting seasonal SARS-CoV-2 mutations

In a study published in Science Translational Medicine, researchers have been trying to create a technique to predict which of these mutations will spread.

13 Jan 2022

COVID-19 infection sera analysis against varying antigens of SARS-CoV-2 variants

In a new study, researchers assessed the sera from COVID-19 infected and vaccinated individuals against the receptor-binding domain in the spike protein of the SARS-CoV-2 wildtype virus and its variants.

13 Jan 2022

Low incidence strategy for control of COVID-19

In a study published in The Lancet Regional Health – Europe, researchers from the Institute for Advanced Studies in Vienna argued for the benefits of a low incidence strategy to control the disease.

13 Jan 2022

Nanovaccines and their immunomodulatory effect against human viruses

A review ]presented the primary progress of nanovaccines against the main viral illnesses.

13 Jan 2022

The unique T cell response elicited by SARS-CoV-2 during a primary immune response by infection and vaccination

The distinctive characteristics of the T cell response generated by SARS-CoV-2 infection and vaccination and the relationship to CCCoVs and VOC was explored in a review published in Frontiers in Medicine.

13 Jan 2022

Using lab-grown stomachs to shed light on the symptoms of COVID-19

Could lab-grown 'mini-stomachs' be used to look at COVID-19 symptoms in children? In this interview, we speak to Paolo De Coppi to find out more.

13 Jan 2022

Cannabinoids may prevent infection with SARS-CoV-2, including variants

A new study published in the Journal of Natural Products of the American Chemical Society and American Society of Pharmacognosy has shown that isolated cannabinoids or those in hemp extracts have the potential to prevent and treat the infection with the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) – primarily by blocking viral cell entry.

13 Jan 2022

A clinical tool for monoclonal antibody allocation to treat COVID-19

In this research paper, a group of Mayo Clinic researchers discusses how data from MATRx's clinical prioritizing algorithms can be used to address anti-spike monoclonal antibody allocation during times of scarcity.

13 Jan 2022

The zoonotic potential of epidemic porcine deltacoronavirus

The present state of knowledge about the genesis, evolution, cross-species transmission, and zoonotic potential of PDCoV is the subject of a review published in the journal Pathogens, which was conducted in a combined effort by researchers from Heilongjiang Bayi Agricultural University and Ohio State University.

13 Jan 2022

Lack of evidence cross-reactive adaptive immune response is mechanism underlying COVID vaccine-induced myocarditis

Recently, the researchers from the USA, in their study published in the journal EBioMedicine, have conducted a sequence identity comparison and 3D protein structure comparison between the SARS-CoV-2 spike protein-derived peptides/protein and myocarditis-associated antigens and have found no significant enrichment in the frequency of spike-derived peptides similar to myocarditis-associated antigens that could have resulted in adaptive autoimmune responses leading to myocarditis.

12 Jan 2022

How did the COVID pandemic affect the spread of other zoonotic diseases?

In new research, scientists from the Beijing University of Technology have been investigating the impact of the COVID-19 pandemic on the incidence and mortality of zoonotic diseases in China. Their work is published in the journal BMJ Global Health.

12 Jan 2022

Disease/Infection News

Prevalence of persistent Long COVID symptoms after SARS-CoV-2 infection

Analyzing milk produced after maternal COVID-19 diagnosis for the presence of SARS-CoV-2

Researchers develop a website to identify SARS-CoV-2 regional clusters in real-time

Vaccination offers long-term protection from worst outcomes of COVID-19

Role of leptin in immune modulation and pathophysiology of COVID-19

Study finds SARS-CoV-2 infection caused significant changes in the levels of stress associated small RNAs

Exploring healthcare workers' opinions on mandatory COVID-19 vaccination in the UK

SARS-CoV-2-specific immune responses elicited by inactivated COVID-19 vaccines

Exploring factors favoring transmission of SARS-CoV-2 Delta sublineage AY.4.2 over the Delta variant

Forecasting seasonal SARS-CoV-2 mutations

COVID-19 infection sera analysis against varying antigens of SARS-CoV-2 variants

Low incidence strategy for control of COVID-19

Nanovaccines and their immunomodulatory effect against human viruses

The unique T cell response elicited by SARS-CoV-2 during a primary immune response by infection and vaccination

Using lab-grown stomachs to shed light on the symptoms of COVID-19

Cannabinoids may prevent infection with SARS-CoV-2, including variants

A clinical tool for monoclonal antibody allocation to treat COVID-19

The zoonotic potential of epidemic porcine deltacoronavirus

Lack of evidence cross-reactive adaptive immune response is mechanism underlying COVID vaccine-induced myocarditis

How did the COVID pandemic affect the spread of other zoonotic diseases?

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News